ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider with focus on cell line engineering, process development (upstream- and downstream process) and GMP manufacturing of biopharmaceuticals. Having almost 20 years of experience in mammalian cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain, including regulatory support for IND-filing. All of our services and technologies are embedded in a total quality management system to assure compliance with international ISO and GMP standards (EMA/FDA).
Founded in 1994, ProBioGen’s reputation is based on a highly dedicated specialist team who strives for excellence in quality and speed in every project. We are led by a seasoned management team with more than 60 years of experience in the biopharmaceutical industry.
Beyond offering state-of-the-art, fee-for-service-based services from cell line development up to GMP manufacturing, we also developed various innovative technologies for optimized biopharmaceutical manufacturing and analysis.
Our partners esteem us for outstanding service quality, combined with variable project and deal structures, responsiveness and flexibility. We are the partner of choice for biopharmaceutical companies seeking high quality cell line development and manufacturing capabilities since we enable your biopharmaceutical vision.
Our State-of-the-Art Services contain: